Cancer Research Cancer Research Funding Available  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mihailovic, T.
Right arrow Articles by Seufferlein, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mihailovic, T.
Right arrow Articles by Seufferlein, T.
[Cancer Research 64, 8939-8944, December 15, 2004]
© 2004 American Association for Cancer Research


Regular Articles

Protein Kinase D2 Mediates Activation of Nuclear Factor {kappa}B by Bcr-Abl in Bcr-Abl+ Human Myeloid Leukemia Cells

Tamara Mihailovic1, Martin Marx1, Alexandra Auer1, Johan Van Lint3, Mathias Schmid2, Christoph Weber1 and Thomas Seufferlein1

Departments of 1 Internal Medicine I and 2 Internal Medicine III, University of Ulm, Germany, and 3 Afdeling Biochemie, Katholieke Universiteit Leuven, Leuven, Belgium

The Bcr-Abl tyrosine kinase activates various signaling pathways including nuclear factor {kappa}B that mediate proliferation, transformation, and apoptosis resistance in Bcr-Abl+ myeloid leukemia cells. Here we report that protein kinase (PK) D2, a serine threonine kinase of the PKD family, is a novel substrate of Bcr-Abl. PKD2 was found to be the major isoform of the PKD family expressed in chronic myeloid leukemia cells and is tyrosine phosphorylated by Bcr-Abl in its pleckstrin homology domain. A mutant that mimicks tyrosine phosphorylation of PKD2 in the pleckstrin homology domain activates nuclear factor {kappa}B independently of its catalytic activity. Furthermore, our data show that Bcr-Abl–induced activation of the nuclear factor {kappa}B cascade in LAMA84 cells is largely mediated by tyrosine-phosphorylated PKD2. These data present a novel mechanism of Bcr-Abl–induced nuclear factor {kappa}B activation in myeloid leukemia. Targeting PKD2 tyrosine phosphorylation, not its kinase activity, could be a novel therapeutic approach for the treatment of Bcr-Abl+ myeloid leukemia.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. Sinnett-Smith, R. Jacamo, R. Kui, Y. M. Wang, S. H. Young, O. Rey, R. T. Waldron, and E. Rozengurt
Protein Kinase D Mediates Mitogenic Signaling by Gq-coupled Receptors through Protein Kinase C-independent Regulation of Activation Loop Ser744 and Ser748 Phosphorylation
J. Biol. Chem., May 15, 2009; 284(20): 13434 - 13445.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Hao, L. Wang, Z. J. Zhao, and H. Tang
Identification of Protein Kinase D2 as a Pivotal Regulator of Endothelial Cell Proliferation, Migration, and Angiogenesis
J. Biol. Chem., January 9, 2009; 284(2): 799 - 806.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. Yuan, A. Lugea, L. Zheng, I. Gukovsky, M. Edderkaoui, E. Rozengurt, and S. J. Pandol
Protein kinase D1 mediates NF-{kappa}B activation induced by cholecystokinin and cholinergic signaling in pancreatic acinar cells
Am J Physiol Gastrointest Liver Physiol, December 1, 2008; 295(6): G1190 - G1201.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. Monteghirfo, F. Tosetti, C. Ambrosini, S. Stigliani, S. Pozzi, F. Frassoni, G. Fassina, S. Soverini, A. Albini, and N. Ferrari
Antileukemia effects of xanthohumol in Bcr/Abl-transformed cells involve nuclear factor-{kappa}B and p53 modulation
Mol. Cancer Ther., September 1, 2008; 7(9): 2692 - 2702.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Jacamo, J. Sinnett-Smith, O. Rey, R. T. Waldron, and E. Rozengurt
Sequential Protein Kinase C (PKC)-dependent and PKC-independent Protein Kinase D Catalytic Activation via Gq-coupled Receptors: DIFFERENTIAL REGULATION OF ACTIVATION LOOP SER744 AND SER748 PHOSPHORYLATION
J. Biol. Chem., May 9, 2008; 283(19): 12877 - 12887.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Doppler and P. Storz
A Novel Tyrosine Phosphorylation Site in Protein Kinase D Contributes to Oxidative Stress-mediated Activation
J. Biol. Chem., November 2, 2007; 282(44): 31873 - 31881.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. M. Bhende, S. J. Dickerson, X. Sun, W.-H. Feng, and S. C. Kenney
X-Box-Binding Protein 1 Activates Lytic Epstein-Barr Virus Gene Expression in Combination with Protein Kinase D
J. Virol., July 15, 2007; 81(14): 7363 - 7370.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
T. T. Chiu, W. Y. Leung, M. P. Moyer, R. M. Strieter, and E. Rozengurt
Protein kinase D2 mediates lysophosphatidic acid-induced interleukin 8 production in nontransformed human colonic epithelial cells through NF-{kappa}B
Am J Physiol Cell Physiol, February 1, 2007; 292(2): C767 - C777.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Feng, M. Ren, and C. S. Rubin
Conserved Domains Subserve Novel Mechanisms and Functions in DKF-1, a Caenorhabditis elegans Protein Kinase D
J. Biol. Chem., June 30, 2006; 281(26): 17815 - 17826.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Feng, M. Ren, S.-L. Wu, D. H. Hall, and C. S. Rubin
Characterization of a Novel Protein Kinase D: CAENORHABDITIS ELEGANS DKF-1 IS ACTIVATED BY TRANSLOCATION-PHOSPHORYLATION AND REGULATES MOVEMENT AND GROWTH IN VIVO
J. Biol. Chem., June 30, 2006; 281(26): 17801 - 17814.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. A. Matthews, P. Liu, M. Spitaler, E. N. Olson, T. A. McKinsey, D. A. Cantrell, and A. M. Scharenberg
Essential Role for Protein Kinase D Family Kinases in the Regulation of Class II Histone Deacetylases in B Lymphocytes
Mol. Cell. Biol., February 15, 2006; 26(4): 1569 - 1577.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. Auer, J. von Blume, S. Sturany, G. von Wichert, J. Van Lint, J. Vandenheede, G. Adler, and T. Seufferlein
Role of the Regulatory Domain of Protein Kinase D2 in Phorbol Ester Binding, Catalytic Activity, and Nucleocytoplasmic Shuttling
Mol. Biol. Cell, September 1, 2005; 16(9): 4375 - 4385.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Rozengurt, O. Rey, and R. T. Waldron
Protein Kinase D Signaling
J. Biol. Chem., April 8, 2005; 280(14): 13205 - 13208.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.